Evidence map›Paper›PMID 24856105›Full record

ArticleBiomaterials2014

A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP.

Xueqin Gao, Arvydas Usas, Ying Tang, Aiping Lu, Jian Tan, Johannes Schneppendahl, Adam M Kozemchak, Bing Wang, James H Cummins, Rocky S Tuan and 1 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Stem Cells and Bone Tissue Engineering.Life (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xueqin GaoStem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, United States.
Arvydas UsasStem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, United States.
Ying TangStem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, United States; Molecular Therapy Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Aiping LuStem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, United States.
Jian TanCenter for Cellular and Molecular Engineering, University of Pittsburgh, Pittsburgh, PA, United States.
Johannes SchneppendahlStem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, United States.
Adam M KozemchakNeuroscience Program, University of Michigan Class of 2013, Pittsburgh Tissue Engineering Initiative Summer Internship, United States.
Bing WangMolecular Therapy Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
James H CumminsStem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, United States.
Rocky S TuanCenter for Cellular and Molecular Engineering, University of Pittsburgh, Pittsburgh, PA, United States.
Johnny HuardStem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address: jhuard@pitt.edu.
University of Pittsburgh · USPittsburgh Tissue Engineering Initiative · US

Funding

Muscle Based Tissue Engineering to Improve Bone HealingR01DE013420 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUARD, JOHNNY · 2001 to 2010
$3.6M
NIDCR NIH HHS 5R01-DE13420-09NIDCR NIH HHS R01 DE013420
6 · The paper itself

Abstract

Adult multipotent stem cells have been isolated from a variety of human tissues including human skeletal muscle, which represent an easily accessible source of stem cells. It has been shown that human skeletal muscle-derived stem cells (hMDSCs) are muscle-derived mesenchymal stem cells capable of multipotent differentiation. Although hMDSCs can undergo osteogenic differentiation and form bone when genetically modified to express BMP2; it is still unclear whether hMDSCs are as efficient as human bone marrow mesenchymal stem cells (hBMMSCs) for bone regeneration. The current study aimed to address this question by performing a parallel comparison between hMDSCs and hBMMSCs to evaluate their osteogenic and bone regeneration capacities. Our results demonstrated that hMDSCs and hBMMSCs had similar osteogenic-related gene expression profiles and had similar osteogenic differentiation capacities in vitro when transduced to express BMP2. Both the untransduced hMDSCs and hBMMSCs formed very negligible amounts of bone in the critical sized bone defect model when using a fibrin sealant scaffold; however, when genetically modified with lenti-BMP2, both populations successfully regenerated bone in the defect area. No significant differences were found in the newly formed bone volumes and bone defect coverage between the hMDSC and hBMMSC groups. Although both cell types formed mature bone tissue by 6 weeks post-implantation, the newly formed bone in the hMDSCs group underwent quicker remodelling than the hBMMSCs group. In conclusion, our results demonstrated that hMDSCs are as efficient as hBMMSCs in terms of their bone regeneration capacity; however, both cell types required genetic modification with BMP in order to regenerate bone in vivo.

Indexed as

AdultBone and BonesBone Morphogenetic Protein 2Bone RegenerationCell DifferentiationCells, CulturedFemaleGenetic VectorsHumansLentivirusMaleMesenchymal Stem CellsMultipotent Stem CellsMuscle CellsMuscle, SkeletalOsteogenesisBMP2 protein, humanBone Morphogenetic Protein 2BMP2Bone tissue engineeringCalvarial defectHuman bone marrow mesenchymal stem cellsHuman muscle-derived stem cellsLentivirus

Identifiers

PMID24856105
PMCPMC4101694
OpenAlexW2068720223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.